Frank Mottola - 05 Feb 2025 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
SVP, Quality, GMP, Ops, IT
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Issuer symbol
SUPN
Transactions as of
05 Feb 2025
Net transactions value
$0
Form type
4
Filing time
06 Feb 2025, 16:57:05 UTC
Previous filing
29 Jan 2025
Next filing
19 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SUPN Common Stock 8,451 05 Feb 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Performance Share Units Award $0 +3,750 $0.000000 3,750 05 Feb 2025 Common Stock 3,750 $0.000000 Direct F1
transaction SUPN Performance Share Units Award $0 +2,010 $0.000000 2,010 05 Feb 2025 Common Stock 2,010 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024.
F2 On February 22, 2022, the Reporting Person was awarded Performance Share Units, portions of which vested upon the achievement of individual performance objectives within defined performance periods, which objectives were established on May 3, 2022.